NCT00873639View on ClinicalTrials.gov

Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

CompletedOBSERVATIONAL
Enrollment

417

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

insulin aspart

Effectiveness and safety data collection in connection with the use of the drug NovoRapid® and Levemir® in routine clinical practice

DRUG

insulin detemir

Effectiveness and safety data collection in connection with the use of the drug NovoRapid® and Levemir® in routine clinical practice

Trial Locations (1)

010031

Novo Nordisk Investigational Site, Bucharest

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00873639 - Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues | Biotech Hunter | Biotech Hunter